European Journal of Pharmacology 2018
A functioning enteroinsular axis is essential for the maintenance of normal glucose tolerance
Preparing thoughtful questions facilitates shared decision-making and ensures you understand the rationale, expectations, and monitoring requirements for your treatment plan
After at least two years of treatment, GLP-1 users had a 37 percent higher chance of developing alopecia than patients taking SGLT-2 drugs and 68 percent higher odds than those taking DPP-4 drugs, both of which are also used to treat type 2 diabetes
10.1016/j.jacc.2024.08.038 [DOI] [PubMed] [Google Scholar] Pinget M., Goldenberg R., Niemoeller E., Muehlen-Bartmer I., Guo H., Aronson R
PA potential solution for this challenge is to explore formulations offering less frequent injections andral formulations, which may provide a more viable long-term treatment solution